Gujarat Terce Laboratories Share Price

Small Cap | Pharmaceuticals and health care | BSE: 524314

₹79.45 image0.27 (0.34 %)

Last Updated: 11 Feb 2025 12:26 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 79.00

High (₹) 81.95

Low (₹) 78.00

Prev. Close (₹) 79.18

Volume 150

VWAP (₹) 77.60

ROCE (%) 10.95

Industry P/E 47.86

TTM P/E 19.96

P/B Ratio 8.29

Market Cap (₹) Cr.58.95

Dividend Yield (%)--

EPS (₹) 0.33

ROE3.44%

Sales Growth (%) 2.55

Profit Growth (%)-114.56

Day Range

81.9581.95

L
H

52 Week Range

27.0294.90

L
H

Historical Returns

Returns (6M)

69.04 %

Returns (1Y)

179.36 %

Returns (3Y)

387.42 %

Returns (5Y)

1098.34 %

Returns (6M)

69.04 %

Returns (1Y)

179.36 %

Returns (3Y)

387.42 %

Returns (5Y)

1098.34 %

SWOT Analysis

  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Bullish MACD crossover (12,6,9) indicates potential upward price movement.
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 67.72

MFI 38.27

ATR 5.11

Commodity Channel Index 9.48

ROC125 45.59

ROC21 -0.73

Williams %R -85.40

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current79.5282.5884.2177.8974.8373.2070.14
Week Ago80.2282.3683.8278.7676.6275.1673.02
Month Ago79.4382.9584.9177.4773.9571.9968.47

EMA & SMA
info_icon

79.45

Current Price

EMA & SMApin

Bullish Moving Averages

18

Bearish Moving Averages

2

5 Day 78.43


9 Day 78.17


10 Day 78.26


12 Day 79.29


14 Day 78.71

20 Day 76.47


26 Day 77.73


50 Day 79.65


100 Day 79.25


200 Day 66.89

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
MABLE RAJESHbulkBuy15 Apr, 2024₹52.4073,000BSE
DHANPAT M KOTHARIbulkBuy17 Nov, 2023₹24.9244,772BSE
RISHABH NEGIbulkBuy15 Nov, 2022₹18.6075,000BSE
GUPTAbulkSell25 Aug, 2022₹20.7843,893BSE
RADHIKA RASTOGIbulkSell16 Jun, 2022₹32.9271,782BSE
RADHIKA RASTOGIbulkBuy16 Jun, 2022₹33.2511BSE
SATYA PRAKASH MITTAL HUFbulkSell15 Jun, 2022₹34.101,19,846BSE
SATYA PRAKASH MITTAL HUFbulkSell03 Jun, 2022₹42.2144,699BSE
SATYA PRAKASH MITTAL HUFbulkBuy03 Jun, 2022₹40.901,286BSE
KANCHAN JOSHIbulkBuy01 Jun, 2022₹35.8647,600BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
06 Nov, 2024Manjulaben S. PrajapatiDisposal9,27,150BSE
06 Nov, 2024Aalap Natwarbhai PrajapatiAcquisition9,27,150BSE
17 Feb, 2024Natwarbhai PrajapatiAcquisition₹28.0012,055BSE
28 Nov, 2023Natwarbhai PrajapatiAcquisition₹26.415370946246112838738338524,502BSE
17 Nov, 2023Natwarbhai PrajapatiAcquisition₹23.00998BSE
29 Sept, 2023Natwarbhai PrajapatiAcquisition₹23.8913,000BSE
29 Sept, 2023Aalap PrajapatiAcquisition₹26.019304347826086956521739135,750BSE
15 Sept, 2023Natwarbhai PrajapatiAcquisition₹20.001,085BSE
13 Jun, 2023Natwarbhai PrajapatiAcquisition₹27.893541666666666666666666679,600BSE
02 Jun, 2023Natwarbhai PrajapatiAcquisition₹21.353846153846153846153846151,300BSE

Corporate Actions

No corporate actions available.

Announcements

DateSourceDetail
04 Feb, 2025BSE IndiaInvestor Presentation for the quarter ended 31.12.2024.
04 Feb, 2025BSE IndiaUnaudited Financial Results for quarter ended on 31.12.2024
04 Feb, 2025BSE IndiaUnaudited Financial Results for quarter ended on 31.12.2024
27 Jan, 2025BSE IndiaGUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 ,inter alia, to consider and approve Unaudited Financial Results of the company for the Quarter ended on 31st December, 2024.
16 Jan, 2025BSE IndiaCompliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 as received from our RTA
03 Jan, 2025BSE IndiaNon-applicability of Corporate Governance under Regulation 2792) of SEBI (LODR) Regulations, 2015 for the quarter ended 31st December, 2024.
30 Oct, 2024BSE IndiaThis letter is in continuation with earlier Financial Results and outcome submitted for the Board Meeting held on 28.10.2024.\r\nRevised Statement is also attached.
28 Oct, 2024BSE IndiaInvestors Presentation for the quarter and half year ended 30th September, 2024
28 Oct, 2024BSE IndiaUnaudited Financial Results for the Quarter and half year ended on September 30, 2024
28 Oct, 2024BSE IndiaOutcome of Board Meeting held on 28th October, 2024 at 06:00 pm

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--28 Jan, 202504 Feb, 2025
Quarterly Results & A.G.M.--21 Oct, 202428 Oct, 2024
Quarterly Results & A.G.M.--05 Aug, 202409 Aug, 2024
Audited Results--22 May, 202429 May, 2024
Preferential issue of shares--23 Mar, 202429 Mar, 2024
Quarterly Results--24 Jan, 202405 Feb, 2024
Quarterly Results--02 Nov, 202308 Nov, 2023
Quarterly Results--24 Jul, 202311 Aug, 2023
Audited Results--05 May, 202313 May, 2023
Quarterly Results--26 Jan, 202331 Jan, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Gujarat Terce Laboratories

Gujarat Terce Laboratories is a Public Limited Listed company incorporated on 28/03/1985 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24100GJ1985PLC007753 and registration number is 007753. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 47.97 Cr. and Equity Capital is Rs. 7.42 Cr. for the Year ended 31/03/2024.  Read More

Parent Organisation

Not Applicable

Founded

1985

Managing Director

Mr. Aalap Prajapat

NSE Symbol

--

Gujarat Terce Laboratories Management

NameDesignation
Mr. Natwarbhai P PrajapatiChairman
Mr. Amrutbhai P PrajapatiWhole Time Director
Mr. Aalap PrajapatManaging Director & CEO
Mrs. Chhayaben A ShahIndependent Director
Mr. Viplav S KhamarIndependent Director
Mr. Surendra Kumar SharmaIndependent Director
Mr. Navinchandra PatelIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
SunPhrmInds₹4,46,576.22₹1,711.20 image
₹1,732.10(-1.21%)
₹1,249.800 - ₹1,960.200
Divis Labora₹1,56,123.40₹5,923.40 image
₹5,938.80(-0.26%)
₹3,350.050 - ₹6,448.750
Cipla₹1,21,675.13₹1,456.85 image
₹1,458.85(-0.14%)
₹1,240.700 - ₹1,702.000
ManKind Phar₹1,18,478.90₹2,455.50 image
₹2,502.05(-1.86%)
₹1,910.100 - ₹3,050.000
DrReddysLab₹1,15,939.04₹1,214.00 image
₹1,220.95(-0.57%)
₹1,104.690 - ₹1,420.200

FAQs on Gujarat Terce Laboratories

What is the share price of Gujarat Terce Laboratories?

The share price of Gujarat Terce Laboratories on 11 Feb, 2025 is ₹ 79.45.

What is 52W high and 52W low share price of Gujarat Terce Laboratories?

The highest and lowest 52W share prices of Gujarat Terce Laboratories are ₹ 94.900 and ₹ 26.640

What is the market cap of Gujarat Terce Laboratories?

The market capitalization of Gujarat Terce Laboratories as of 11 Feb, 2025 is ₹ 58.95 Crores

What is the P/E ratio of Gujarat Terce Laboratories?

The current P/E ratio of Gujarat Terce Laboratories as of 11 Feb, 2025 is 47.86

What is the PB ratio of Gujarat Terce Laboratories?

The PB ratio of Gujarat Terce Laboratories as of 11 Feb, 2025 is 8.29

Top Gainers

948IHFL26I

IBHFL NCD186

₹845image

₹705 (0.2%)

GREAVESCOT

Greaves

₹281.85image

₹234.9 (0.2%)

ASHSI

Ashirwd Stl

₹45.66image

₹38.05 (0.2%)

CAPRO

Caprola.Chem

₹62.4image

₹52 (0.2%)

Top Losers

DHANBANK

Dhanalak.Bnk

₹32.19image

₹35.97 (-0.11%)

08MPD

08MPD

₹8.66image

₹9.62 (-0.1%)

BALTE

BalurghtTran

₹27.13image

₹31.24 (-0.13%)

DARSHANORNA

Darshan Orna

₹4.57image

₹5.07 (-0.1%)

Market Indices

Sensex

₹78,699.07image

₹78,472.48 (0%)

Source : Dion Global Solutions Limited